Skip to main content
2024 CRT Conference Main banner
Back

Charles A. Simonton, MD, FACC, FSCAI

EVP Chief Medical Officer
Abiomed Inc
Charlotte, North Carolina, United States

Charles Simonton, MD joined Abiomed in June 2020 as Vice President and Chief Medical Officer. He is renowned for his leadership in product development and large-scale clinical trials. From 2008-2019 he was at Abbott Vascular where he served as chief medical officer and divisional vice president of global medical affairs. He led the programs that resulted in the FDA's approval of carotid stents, MitraClip™ and Absorb BVS, in addition to the EXCEL and COAPT trials. Prior to Abbott, Dr. Simonton spent 25 years as an interventional cardiologist working with complex cardiac and vascular patients at Duke University Medical Center and the Sanger Clinic in Charlotte NC. He received his medical degree from Harvard Medical School and did his internship, residency and chief residency in the Department of Internal Medicine at the University of California and his cardiology fellowship at Duke University.

Disclosure information not submitted.

Presentation(s):